Press Release Ernexa Therapeutics Participates in the Virtual Investor “Why Now” On-Demand Conference Aug 27
Press Release Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage Aug 10
Press Release Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies Jul 24